Sale!

CCDC40 Gene Primary Ciliary Dyskinesia Type 15 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The CCDC40 Gene Primary Ciliary Dyskinesia Type 15 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE. Priced at 4400 AED, this test specifically targets the CCDC40 gene to identify mutations that are responsible for Primary Ciliary Dyskinesia (PCD) Type 15. PCD is a rare genetic disorder characterized by chronic respiratory tract infections, abnormal organ positioning, and infertility due to defects in the structure and function of cilia, which are microscopic, hair-like structures that line the airways, reproductive system, and other parts of the body.

The CCDC40 gene plays a crucial role in the proper assembly and function of cilia. Mutations in this gene can disrupt ciliary motion, leading to the symptoms associated with PCD. The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory to detect any genetic abnormalities in the CCDC40 gene.

Offered at DNA Labs UAE, this genetic test is vital for early diagnosis and management of PCD Type 15. It not only helps in understanding the genetic basis of the condition but also assists in making informed decisions regarding treatment options and family planning. Early diagnosis through this genetic test can significantly improve the quality of life for individuals with PCD Type 15 by allowing for timely interventions and management strategies to alleviate symptoms and prevent complications.

Description

CCDC40 Gene Primary ciliary dyskinesia type 15 Genetic Test

Components: Price – 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test type: Ear Nose Throat Disorders

Doctor: ENT Doctor

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia NGS Genetic DNA Test gene IARS17

Test Details:

The CCDC40 gene is associated with primary ciliary dyskinesia type 15, which is a genetic disorder that affects the function of cilia. Cilia are hair-like structures found on the surface of cells and are involved in various important functions, including the movement of mucus and other substances in the respiratory tract.

Primary ciliary dyskinesia (PCD) is a rare genetic disorder characterized by impaired ciliary function, leading to recurrent respiratory infections, chronic sinusitis, bronchiectasis, and other respiratory symptoms. PCD can also affect the functioning of other organs, such as the ears, nose, and reproductive system.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that can analyze multiple genes simultaneously to identify mutations or variations that may be associated with a specific disorder. In the case of primary ciliary dyskinesia type 15, NGS genetic testing can be used to identify mutations or variations in the CCDC40 gene that may be responsible for the disorder.

NGS genetic testing for primary ciliary dyskinesia type 15 can be helpful in confirming a diagnosis, identifying carriers of the gene mutation, and providing information for genetic counseling. It can also be used for prenatal testing in families with a known mutation in the CCDC40 gene.

It’s important to note that genetic testing should be done in consultation with a healthcare professional or genetic counselor who can provide guidance and interpretation of the results. They can also help determine the appropriate testing strategy based on an individual’s symptoms, family history, and other factors.

Test Name	CCDC40 Gene Primary ciliary dyskinesia type 15 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Ear Nose Throat Disorders
Doctor	ENT Doctor
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia NGS Genetic DNA Test gene IARS17
Test Details	The CCDC40 gene is associated with primary ciliary dyskinesia type 15, which is a genetic disorder that affects the function of cilia. Cilia are hair-like structures found on the surface of cells and are involved in various important functions, including the movement of mucus and other substances in the respiratory tract. Primary ciliary dyskinesia (PCD) is a rare genetic disorder characterized by impaired ciliary function, leading to recurrent respiratory infections, chronic sinusitis, bronchiectasis, and other respiratory symptoms. PCD can also affect the functioning of other organs, such as the ears, nose, and reproductive system. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that can analyze multiple genes simultaneously to identify mutations or variations that may be associated with a specific disorder. In the case of primary ciliary dyskinesia type 15, NGS genetic testing can be used to identify mutations or variations in the CCDC40 gene that may be responsible for the disorder. NGS genetic testing for primary ciliary dyskinesia type 15 can be helpful in confirming a diagnosis, identifying carriers of the gene mutation, and providing information for genetic counseling. It can also be used for prenatal testing in families with a known mutation in the CCDC40 gene. It’s important to note that genetic testing should be done in consultation with a healthcare professional or genetic counselor who can provide guidance and interpretation of the results. They can also help determine the appropriate testing strategy based on an individual’s symptoms, family history, and other factors.